Parallel Bio
https://parallel.bioUsing the immune system to cure disease
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Our platform has all of the same elements as a human immune system, meaning you can test drugs and vaccines as if you were testing them in actual patients from the start. The biggest reason why 95% of new drugs fail is that they were tested in mice - but with our human platform, pharma companies will know which drugs will successfully treat patients, speeding up the process and reducing the cost. To date our platform has successfully been used to test 12 drugs, and vaccines against 8 different diseases. The company is founded by Robert DiFazio, a former Stanford R&D director with a PhD in immunology, and Juliana Hilliard, a former System1 Biosciences R&D lead with an MSc in bioengineering, both of whom have led drug discovery programs for years.
Total Open and Closed Positions
Total open positions, and positions newly closed since the previous update
Department Headcount Over Time
Open positions per department · top 6 at any point in the window
Newly Opened and Closed Positions
Position Churn Rate
Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels
Time-to-Fill Distribution
Days from open to close · closed positions only
Salary Trend Over Time
Monthly median base salary · USD · annualized · p25/p75 dashed
Salary Range by Department
Employment Type
Technical vs. Non-technical
Open positions · by department
Top Roles by Department
Seniority Mix
Derived from job title keywords
Equity Range by Department
Top Skills
Top Tech Stacks
Skills Trend
Change in share of postings · recent 3 months vs. prior 3 months
Tech Stack Evolution
Positions opened per month · top 5 technologies